Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206-1214. 441. Pokorney SD, Rao MP, Wojdyla DM, et al. Abstract 17277: apixaban use in patients with atrial brillation with bioprosthetic valves: insights from ARISTOTLE. Circulation. 2015;132(suppl 3). A17277-A17277. 442. Carnicelli AP, De Caterina R, Halperin JL, et al. Edoxaban for the prevention of thromboembolism in patients with atrial brillation and bioprosthetic valves. Circulation. 2017;135(13):1273-1275. 443. Petronio AS, Capranzano P, Barbato E, et al. Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II). EuroIntervention. 2017;12(16):1934-1939. 444. De Caterina R, John Camm A. Non-vitamin K antagonist oral anticoagulants in atrial brillation accompanying mitral stenosis: the concept for a trial. Europace. 2016;18(1):6-11. 445. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial brillation. Ann Thoracic Surg. 1996;61(2):755-759. 446. Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial brillation: a randomized clinical trial. JAMA. 2014;312(19):1988-1998. 447. Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial brillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127(6):720-729. 448. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123(4):417-424. 449. Main ML, Fan D, Reddy VY, et al. Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial brillation (from the PROTECT-AF Trial). 